Viscosupplementation in Patients with Osteoarthritis of the Knee

References

• . Goldberg VM, Goldberg L. Intra-articular hyaluronans: the treatment of knee pain in osteoarthritis. J Pain Res. 2010;3:51–56
   PubMedGoogle Scholar
• . Bellamy N, Campbell J, Robinson V, Gee T, Bourne R, Wells G. Viscosupplementation for the treatment of osteoarthritis of the knee. Cochrane Database Syst Rev. 2006;2:CD005321
   PubMed Web of Science ®Google Scholar
• . Felson DT. Clinical practice. Osteoarthritis of the knee. N Engl J Med. 2006;354(8):841–848
   PubMed Web of Science ®Google Scholar
• . Puenpatom RA, Victor TW. Increased prevalence of metabolic syndrome in individuals with osteoarthritis: an analysis of NHANES III data. Postgrad Med. 2009;121(6):9–20
   PubMed Web of Science ®Google Scholar
• . Centers for Disease Control and Prevention. Osteoarthritis. 2011. http://www.cdc.gov/arthritis/basics/osteoarthritis.htm. Accessed January 2, 2012
   Google Scholar
• . Brandt KD, Dieppe P, Radin EL. Etiopathogenesis of osteoarthritis. Rheum Dis Clin North Am. 2008;34(3):531–559
   PubMed Web of Science ®Google Scholar
• . Mandelbaum B, Waddell D. Etiology and pathophysiology of osteoarthritis. Orthopedics. 2005;28( suppl 21):S207–S214
   Google Scholar
• . Toivanen AT, Heliovaara M, Impivaara O, . Obesity, physically demanding work and traumatic knee injury are major risk factors for knee osteoarthritis—a population-based study with a follow-up of 22 years. Rheumatology (Oxford). 2010;49(2):308–314
   PubMedGoogle Scholar
• . Wieland HAMichaelis M, Kirschbaum BJ, Rudolphi KA. Osteoarthritis—an untreatable disease? Nat Rev Drug Discov. 2005;4(4):331–344
   PubMed Web of Science ®Google Scholar
• . Felson DT, McLaughlin S, Goggins J, . Bone marrow edema and its relation to progression of knee osteoarthritis. Ann Intern Med. 2003;139(5 pt 1):330–336
   PubMed Web of Science ®Google Scholar
• . Lane NE, Brandt K, Hawker G, . OARSI-FDA initiative: defining the disease state of osteoarthritis. Osteoarthritis Cartilage. 2011;19(5):478–482
   PubMed Web of Science ®Google Scholar
• . Jin G, Sah RL, Li YS, Lotz M, Shyy JY, Chien S. Biomechanical regulation of matrix metalloproteinase-9 in cultured chondrocytes. J Orthop Res. 2000;18(6):899–908
   PubMedGoogle Scholar
• . Sharma L, Song J, Felson DT, Cahue S, Shamiyeh E, Dunlop DD. The role of knee alignment in disease progression and functional decline in knee osteoarthritis. JAMA. 2001;286(2):188–195
   PubMed Web of Science ®Google Scholar
• . Abramson SB, Attur M, Yazici Y. Prospects for disease modification in osteoarthritis. Nat Clin Pract Rheumatol. 2006;2(6):304–312
   PubMedGoogle Scholar
• . Pelletier JP, Martel—Pelletier J, Abramson SB. Osteoarthritis, an inflammatory disease: potential implication for the selection of new therapeutic targets. Arthritis Rheum. 2001;44(6):1237–1247
   PubMed Web of Science ®Google Scholar
• . Yuan GH, Masuko—Hongo K, Kato T, Nishioka K. Immunologic intervention in the pathogenesis of osteoarthritis. Arthritis Rheum. 2003;48(3):602–611
   PubMed Web of Science ®Google Scholar
• . Dahl LB, Dahl IM, Engstrom—Laurent A, Granath K. Concentration and molecular weight of sodium hyaluronate in synovial fluid from patients with rheumatoid arthritis and other arthropathies. Ann Rheum Dis. 1985;44(12):817–822
   PubMed Web of Science ®Google Scholar
• . Ghosh P, Guidolin D. Potential mechanism of action of intra-articular hyaluronan therapy in osteoarthritis: are the effects molecular weight dependent? Semin Arthritis Rheum. 2002;32(1):10–37
   PubMed Web of Science ®Google Scholar
• . Brockmeier SF, Shaffer BS. Viscosupplementation therapy for osteoarthritis. Sports Med Arthrosc. 2006;14(3):155–162
   PubMed Web of Science ®Google Scholar
• . Fraser JR, Clarris BJ, Baxter E. Patterns of induced variation in the morphology, hyaluronic acid secretion, and lysosomal enzyme activity of cultured human synovial cells. Ann Rheum Dis. 1979;38(3):287–294
   PubMedGoogle Scholar
• . Conduah AH, Baker CL, Baker CL. Managing joint pain in osteoarthritis: safety and efficacy of hylan G-F 20. J Pain Res. 2009;2:87–98
   PubMedGoogle Scholar
• . Brown TJ, Laurent UB, Fraser JR. Turnover of hyaluronan in synovial joints: elimination of labelled hyaluronan from the knee joint of the rabbit. Exp Physiol. 1991;76(1):125–134
   PubMedGoogle Scholar
• . Watterson JR, Esdaile JM. Viscosupplementation: therapeutic mechanisms and clinical potential in osteoarthritis of the knee. J Am Acad Orthop Surg. 2000;8(5):277–284
   PubMedGoogle Scholar
• . Goldberg VM, Buckwalter JA. Hyaluronans in the treatment of osteoarthritis of the knee: evidence for disease-modifying activity. Osteoarthritis Cartilage. 2005;13(3):216–224
   PubMed Web of Science ®Google Scholar
• . Zhang W, Moskowitz RW, Nuki G, . OARSI recommendations for the management of hip and knee osteoarthritis, Part II: OARSI evidence-based, expert consensus guidelines. Osteoarthritis Cartilage. 2008;16(2):137–162
   PubMed Web of Science ®Google Scholar
• . Messier SP. Diet and exercise for obese adults with knee osteoarthritis. Clin Geriatr Med. 2010;26(3):461–477
   PubMed Web of Science ®Google Scholar
• . Clauw D, McCarberg BH. Managing chronic pain with nonopioid analgesics: a multidisciplinary consult. Am J Med. 2012;125(5):S1
   PubMedGoogle Scholar
• . Reginster JY, Neuprez A, Lecart MP, Sarlet N, Bruyere O. Role of glucosamine in the treatment for osteoarthritis. Rheumatol Int. 2012;32(10):2959–2967
   PubMedGoogle Scholar
• . Jordan KM, Arden NK, Doherty M, ; Standing Committee for International Clinical Studies Including Therapeutic Therapeutic Trials ESCISIT EULAR Recommendations 2003: an evidence based approach to the management of knee osteoarthritis: Report of a Task Force of the Standing Committee for International Clinical Studies Including Therapeutic Trials (ESCISIT). Ann Rheum Dis. 2003;62(12):1145–1155
   PubMed Web of Science ®Google Scholar
• . Habib GS. Systemic effects of intra-articular corticosteroids. Clin Rheumatol. 2009;28(7):749–756
   PubMed Web of Science ®Google Scholar
• . Habib GS, Bashir M, Jabbour A. Increased blood glucose levels following intra-articular injection of methylprednisolone acetate in patients with controlled diabetes and symptomatic osteoarthritis of the knee. Ann Rheum Dis. 2008;67(12):1790–1791
   PubMedGoogle Scholar
• . Kirkley A, Birmingham TB, Litchfield RB, . A randomized trial of arthroscopic surgery for osteoarthritis of the knee. N Engl J Med. 2008;359(11):1097–1107
   PubMed Web of Science ®Google Scholar
• . Laupattarakasem W, Laopaiboon M, Laupattarakasem P, Sumananont C. Arthroscopic debridement for knee osteoarthritis. Cochrane Database Syst Rev. 2008;1:CD005118
   Google Scholar
• . Fam H, Bryant JT, Kontopoulou M. Rheological properties of synovial fluids. Biorheology. 2007;44(2):59–74
   PubMed Web of Science ®Google Scholar
• . Sofat N, Ejindu V, Kiely P. What makes osteoarthritis painful? The evidence for local and central pain processing. Rheumatology (Oxford). 2011;50(12):2157–2165
   PubMed Web of Science ®Google Scholar
• . Gotoh S, Onaya J, Abe M, . Effects of the molecular weight of hyaluronic acid and its action mechanisms on experimental joint pain in rats. Ann Rheum Dis. 1993;52(11):817–822
   PubMedGoogle Scholar
• . Pozo MA, Balazs EA, Belmonte C. Reduction of sensory responses to passive movements of inflamed knee joints by hylan, a hyaluronan derivative. Exp Brain Res. 1997;116(1):3–9
   PubMed Web of Science ®Google Scholar
• . Gomis A, Pawlak M, Balazs EA, Schmidt RF, Belmonte C. Effects of different molecular weight elastoviscous hyaluronan solutions on articular nociceptive afferents. Arthritis Rheum. 2004;50(1):314–326
   PubMedGoogle Scholar
• . Iacob S, Knudson CB. Hyaluronan fragments activate nitric oxide synthase and the production of nitric oxide by articular chondrocytes. Int J Biochem Cell Biol. 2006;38(1):123–133
   PubMedGoogle Scholar
• . Maneiro E, de Andres MC, Fernandez—Sueiro JL, Galdo F, Blanco FJ. The biological action of hyaluronan on human osteoartritic articular chondrocytes: the importance of molecular weight. Clin Exp Rheumatol. 2004;22(3):307–312
   PubMedGoogle Scholar
• . Reichenbach S, Blank S, Rutjes AW, . Hylan versus hyaluronic acid for osteoarthritis of the knee: a systematic review and meta-analysis. Arthritis Rheum. 2007;57(8):1410–1418
   PubMed Web of Science ®Google Scholar
• . Gerwin N, Hops C, Lucke A. Intraarticular drug delivery in osteoarthritis. Adv Drug Deliv Rev. 2006;58(2):226–242
   PubMed Web of Science ®Google Scholar
• . Waddell DD. The tolerability of viscosupplementation: low incidence and clinical management of local adverse events. Curr Med Res Opin. 2003;19(7):575–580
   PubMed Web of Science ®Google Scholar
• . Wen DY. Intra-articular hyaluronic acid injections for knee osteoarthritis. Am Fam Physician. 2000;62(3):565–570, 572
   PubMed Web of Science ®Google Scholar
• . Recommendations for the medical management of osteoarthritis of the hip and knee: 2000 update. American College of Rheumatology Subcommittee on Osteoarthritis Guidelines. Arthritis Rheum. 2000;43(9):1905–1915
   PubMed Web of Science ®Google Scholar
• . Hochberg MC, Altman RD, April KT, ; American College of Rheumatology. American College of Rheumatology 2012 recommendations for the use of nonpharmacologic and pharmacologic therapies in osteoarthritis of the hand, hip, and knee. Arthritis Care Res (Hoboken). 2012;64(4):455–474
   PubMed Web of Science ®Google Scholar
• . Zhang W, Nuki G, Moskowitz RW, . OARSI recommendations for the management of hip and knee osteoarthritis: part III: Changes in evidence following systematic cumulative update of research published through January 2009. Osteoarthritis Cartilage. 2010;18(4):476–499
   PubMed Web of Science ®Google Scholar
• . Richmond J, Hunter D, Irrgang J, . Treatment of osteoarthritis of the knee (nonarthroplasty). J Am Acad Orthop Surg. 2009;17(9):591–600
   PubMed Web of Science ®Google Scholar
• . Conrozier T, Chevalier X. Long-term experience with hylan GF-20 in the treatment of knee osteoarthritis. Expert Opin Pharmacother. 2008;9(10):1797–1804
   PubMed Web of Science ®Google Scholar
• . Huang TL, Chang CC, Lee CH, Chen SC, Lai CH, Tsai CL. Intra-articular injections of sodium hyaluronate (Hyalgan®) in osteoarthritis of the knee. A randomized, controlled, double-blind, multicenter trial in the Asian population. BMC Musculoskelet Disord. 2011;12:221
   PubMedGoogle Scholar
• . Navarro—Sarabia F, Coronel P, Collantes E, . A 40-month multicentre, randomised placebo-controlled study to assess the efficacy and carry-over effect of repeated intra-articular injections of hyaluronic acid in knee osteoarthritis: the AMELIA project. Ann Rheum Dis. 2011;70(11):1957–1962
   PubMed Web of Science ®Google Scholar
• . Bannuru RR, Natov NS, Dasi UR, Schmid CH, McAlindon TE. Therapeutic trajectory following intra-articular hyaluronic acid injection in knee osteoarthritis—meta-analysis. Osteoarthritis Cartilage. 2011;19(6):611–619
   PubMed Web of Science ®Google Scholar
• . Wang CT, Lin J, Chang CJ, Lin YT, Hou SM. Therapeutic effects of hyaluronic acid on osteoarthritis of the knee. A meta-analysis of randomized controlled trials. J Bone Joint Surg Am. 2004;86-A(3):538–545
   PubMed Web of Science ®Google Scholar
• . Kemper F, Gebhardt U, Meng T, Murray C. Tolerability and short-term effectiveness of hylan G-F 20 in 4253 patients with osteoarthritis of the knee in clinical practice. Curr Med Res Opin. 2005;21(8):1261–1269
   PubMed Web of Science ®Google Scholar
• . Lussier A, Cividino AA, McFarlane CA, Olszynski WP, Potashner WJ, De Medicis R. Viscosupplementation with hylan for the treatment of osteoarthritis: findings from clinical practice in Canada. J Rheumatol. 1996;23(9):1579–1585
   PubMed Web of Science ®Google Scholar
• . Neustadt DH. Long-term efficacy and safety of intra-articular sodium hyaluronate (Hyalgan) in patients with osteoarthritis of the knee. Clin Exp Rheumatol. 2003;21(3):307–311
   PubMed Web of Science ®Google Scholar
• . Sugimoto H, Yamada H, Terada N, . Intraarticular injection of high molecular weight hyaluronan for osteoarthritis of the knee—prediction of effectiveness with biological markers. J Rheumatol. 2006;33(12):2527
   PubMedGoogle Scholar
• . Jubb RW, Piva S, Beinat L, Dacre J, Gishen P. A one-year, randomised, placebo (saline) controlled clinical trial of 500–730 kDa sodium hyaluronate (Hyalgan) on the radiological change in osteoarthritis of the knee. Int J Clin Pract. 2003;57(6):467–474
   PubMed Web of Science ®Google Scholar
• . Decaria JE, Montero—Odasso M, Wolfe D, Chesworth BM, Petrella RJ. The effect of intra-articular hyaluronic acid treatment on gait velocity in older knee osteoarthritis patients: a randomized, controlled study. Arch Gerontol Geriatr. 2012;55(2):310–315
   PubMedGoogle Scholar
• . Raynauld JP, Torrance GW, Band PA, . A prospective, randomized, pragmatic, health outcomes trial evaluating the incorporation of hylan G-F 20 into the treatment paradigm for patients with knee osteoarthritis (part 1 of 2): clinical results. Osteoarthritis Cartilage. 2002;10(7):506–517
   PubMed Web of Science ®Google Scholar
• . Torrance GW, Raynauld JP, Walker V, . A prospective, randomized, pragmatic, health outcomes trial evaluating the incorporation of hylan G-F 20 into the treatment paradigm for patients with knee osteoarthritis (part 2 of 2): economic results. Osteoarthritis Cartilage. 2002;10(7):518–527
   PubMedGoogle Scholar
• . Chevalier X, Jerosch J, Goupille P, . Single, intra-articular treatment with 6 mL Hylan G-F 20 in patients with symptomatic primary osteoarthritis of the knee: a randomised, multicentre, double-blind, placebo controlled trial. Ann Rheum Dis. 2010;69(1):113–119
   PubMed Web of Science ®Google Scholar
• . Huskin JP, Vandekerckhove B, Delince P, . Multicentre, prospective, open study to evaluate the safety and efficacy of hylan G-F 20 in knee osteoarthritis subjects presenting with pain following arthroscopic meniscectomy. Knee Surg Sports Traumatol Arthrosc. 2008;16(8):747–752
   PubMedGoogle Scholar
• . Hamburger MI, Lakhanpal S, Mooar PA, Oster D. Intra-articular hyaluronans: a review of product-specific safety profiles. Semin Arthritis Rheum. 2003;32(5):296–309
   PubMedGoogle Scholar
• . Burns AW, Bourne RB, Chesworth BM, MacDonald SJ, Rorabeck CH. Cost effectiveness of revision total knee arthroplasty. Clin Orthop Relat Res. 2006;446:29–33
   PubMedGoogle Scholar
• . Waddell DD, Bricker DC. Total knee replacement delayed with hylan G-F 20 use in patients with grade IV osteoarthritis. J Manag Care Pharm. 2007;13(2):113–121
   PubMed Web of Science ®Google Scholar
• . Bagga H, Burkhardt D, Sambrook P, March L. Longterm effects of intraarticular hyaluronan on synovial fluid in osteoarthritis of the knee. J Rheumatol. 2006;33(5):946–950
   PubMed Web of Science ®Google Scholar
• . Wang Y, Hall S, Hanna F, . Effects of Hylan G-F 20 supplementation on cartilage preservation detected by magnetic resonance imaging in osteoarthritis of the knee: a two-year single-blind clinical trial. BMC Musculoskelet Disord. 2011;12:195
   PubMed Web of Science ®Google Scholar
• . Evanich JD, Evanich CJ, Wright MB, Rydlewicz JA. Efficacy of intraarticular hyaluronic acid injections in knee osteoarthritis. Clin Orthop Relat Res. 2001;390:173–181
   PubMedGoogle Scholar
• . Migliore A, Giovannangeli F, Granata M, Lagana B. Hylan G-F 20: review of its safety and efficacy in the management of joint pain in osteoarthritis. Clin Med Insights Arthritis Musculoskelet Disord. 2010;3:55–68
   PubMedGoogle Scholar
• . Punzi L. The complexity of the mechanisms of action of hyaluronan in joint diseases. Clin Exp Rheumatol. 2001;19(3):242–246
   PubMedGoogle Scholar
• . Tamoto K, Tada M, Shimada S, Nochi H, Mori Y. Effects of high-molecular-weight hyaluronates on the functions of guinea pig polymorphonuclear leukocytes. Semin Arthritis Rheum. 1993;22(6 suppl 1):4–8
   PubMedGoogle Scholar
• . Tobetto K, Yasui T, Ando T, . Inhibitory effects of hyaluronan on [14C]arachidonic acid release from labeled human synovial fibroblasts. Jpn J Pharmacol. 1992;60(2):79–84
   PubMedGoogle Scholar
• . Balazs EA, Denlinger JL. Viscosupplementation: a new concept in the treatment of osteoarthritis. J Rheumatol Suppl. 1993;39:3–9
   PubMedGoogle Scholar
• . Shimizu C, Yoshioka M, Coutts RD, . Long-term effects of hyaluronan on experimental osteoarthritis in the rabbit knee. Osteoarthritis Cartilage. 1998;6(1):1–9
   PubMedGoogle Scholar
• . Marshall KW, Manolopoulos V, Mancer K, Staples J, Damyanovich A. Amelioration of disease severity by intraarticular hylan therapy in bilateral canine osteoarthritis. J Orthop Res. 2000;18(3):416–425
   PubMedGoogle Scholar
• . Wang A, de la Motte C, Lauer M, Hascall V. Hyaluronan matrices in pathobiological processes. Febs J. 2011;278(9):1412–1418
   PubMedGoogle Scholar
• . Ghosh P. The role of hyaluronic acid (hyaluronan) in health and disease: interactions with cells, cartilage and components of synovial fluid. Clin Exp Rheumatol. 1994;12(1):75–82
   PubMedGoogle Scholar
• . Balazs EA, Watson D, Duff IF, Roseman S. Hyaluronic acid in synovial fluid. I. Molecular parameters of hyaluronic acid in normal and arthritis human fluids. Arthritis Rheum. 1967;10(4):357–376
   PubMed Web of Science ®Google Scholar
• . Mazzucco D, McKinley G, Scott RD, Spector M. Rheology of joint fluid in total knee arthroplasty patients. J Orthop Res. 2002;20(6):1157–1163
   PubMedGoogle Scholar
• . Gel-One [package insert]. Tokyo, Japan: Seikagaku Corporation; 2011. http://www.zimmer.com/content/pdf/en-US/Gel-One_Pkg_Insert_Final.pdf. May 20, 2011. Accessed 12 October, 2012, 2012
   Google Scholar
• . Arrich J, Piribauer F, Mad P, Schmid D, Klaushofer K, Mullner M. Intra-articular hyaluronic acid for the treatment of osteoarthritis of the knee: systematic review and meta-analysis. CMAJ. 2005;172(8):1039–1043
   PubMed Web of Science ®Google Scholar
• . Bannuru RR, Natov NS, Obadan IE, Price LL, Schmid CH, McAlindon TE. Therapeutic trajectory of hyaluronic acid versus corticosteroids in the treatment of knee osteoarthritis: a systematic review and meta-analysis. Arthritis Rheum. 2009;61(12):1704–1711
   PubMed Web of Science ®Google Scholar
• . Campbell J, Bellamy N, Gee T. Differences between systematic reviews/meta-analyses of hyaluronic acid/hyaluronan/hylan in osteoarthritis of the knee. Osteoarthritis Cartilage. 2007;15(12):1424–1436
   PubMed Web of Science ®Google Scholar
• . Divine JG, Zazulak BT, Hewett TE. Viscosupplementation for knee osteoarthritis: a systematic review. Clin Orthop Relat Res. 2007;455:113–122
   PubMedGoogle Scholar
• . Lo GH, LaValley M, McAlindon T, Felson DT. Intra-articular hyaluronic acid in treatment of knee osteoarthritis: a meta-analysis. JAMA. 2003;290(23):3115–3121
   PubMed Web of Science ®Google Scholar
• . Medina JM, Thomas A, Denegar CR. Knee osteoarthritis: should your patient opt for hyaluronic acid injection? J Fam Pract. 2006;55(8):669–675
   PubMed Web of Science ®Google Scholar
• . Modawal A, Ferrer M, Choi HK, Castle JA. Hyaluronic acid injections relieve knee pain. J Fam Pract. 2005;54(9):758–767
   PubMed Web of Science ®Google Scholar
• . Rutjes AW, Juni P, da Costa BR, Trelle S, Nuesch E, Reichenbach S. Viscosupplementation for osteoarthritis of the knee: a systematic review and meta-analysis. Ann Intern Med. 2012;157(3):180–191
   PubMed Web of Science ®Google Scholar